胃內球囊市場規模、佔有率和成長分析：按產品類型、材料、手術方式、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球胃內球囊市場價值為 1.825 億美元，預計到 2025 年將成長至 2.0334 億美元，到 2033 年將成長至 4.854 億美元，在預測期（2026-2033 年）內複合年成長率為 11.42%。

全球胃內球囊市場正經歷顯著成長，這主要得益於肥胖症治療保險報銷範圍的擴大，從而提高了患者接受度和市場潛力。隨著保險公司認知到球囊置入帶來的健康益處，例如降低糖尿病和心血管疾病的風險，胃腸病中心正在增加對相關培訓和設備的投資。歐洲醫院與合規追蹤平台之間合作的加強也推動了這一趨勢，從而改善了患者的治療效果。此外，隨著亞洲法規核准流程的加快，創新可生物分解球囊的推出預計將進一步擴大市場佔有率。人工智慧（AI）透過分析健康記錄和生活方式數據，正在改變患者選擇方式，並透過實現個人化治療方案，進一步推動市場成長，從而改善治療效果並簡化臨床操作。

全球胃內球囊市場的成長要素

消費者對非手術減肥方法的興趣日益濃厚，顯著推動了胃內球囊的需求成長。患者越來越傾向於尋求能夠最大限度降低手術風險、縮短恢復時間的有效替代方案，這促使內視鏡手術的接受度不斷提高，並擴大了其適用人群。這種轉變不僅促使製造商加大產品研發和行銷方面的投入，也提高了整體市場認知度。此外，人們對胃內球囊安全性的良好認知，加上醫生信心的增強以及微創技術的廣泛應用，正在推動臨床轉診，並為胃內球囊領域的持續成長奠定基礎。

全球胃內球囊市場的限制因素

全球胃內球囊市場面臨許多限制因素，其中最主要的是複雜的監管流程，這些流程要求提交大量的臨床證據和合規文件，往往導致產品上市時間延遲。製造商必須投入大量資源來滿足嚴格的安全標準並遵守各地不同的法規，從而造成市場准入延遲和研發成本上升。這種情況常常阻礙中小企業進入市場，進而抑制整個產業的創新和成長前景。此外，監管的不確定性也導致投資者持謹慎態度。核准結果的不確定性可能會影響投資回報，促使投資人採取更謹慎的資金籌措，進一步阻礙市場擴張。

全球胃內球囊市場趨勢

全球胃內球囊市場正經歷著向微創減重計畫的顯著轉變，因為患者和臨床醫生都優先考慮能夠最大限度減少住院時間、術後疼痛和恢復時間的治療方案。這一趨勢使得胃內球囊療法成為傳統外科減肥手術以外備受追捧的替代方案。隨著醫療機構利用先進的內視鏡技術提升門診服務，實現球囊的高效插入和取出，保險公司也越來越認可這些手術的成本效益。因此，製造商正致力於研發能夠提高耐用性和易用性的材料，並與內視鏡設備製造商合作，開發符合全球微創醫療趨勢的整合解決方案。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球胃內球囊市場規模：依產品類型分類

• 單氣球
• 雙球
• 可吞嚥氣球

全球胃內球囊市場規模：依材料分類

• 矽酮
• 生理食鹽水水填充型
• 充氣式

全球胃內球囊市場規模：依手術類型分類

• 內視鏡置入
• 口服型（非內視鏡型）

全球胃內球囊市場規模：依應用分類

• 肥胖症治療
• 減重手術前

全球胃內球囊市場規模：依最終用戶分類

• 醫院
• 肥胖治療中心
• 門診部

全球胃內球囊市場規模：依地區分類

• 北美洲
• 歐洲
• 中東

全球胃內球囊市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Apollo Endosurgery（ORBERA）
• Obalon Therapeutics（ReShape Lifesciences）
• Reshape Medical（ReShape Lifesciences）
• Spatz Medical
• Allurion Technologies（Elipse）
• Endalis（Endotools）
• BMI Medical（Helioscopie）
• Medical Innovation Developpement（MID）
• Bioenterics Corporation（Allergan/AbbVie）
• Medsil（Russian）
• Medicone Medical
• Ethicon（J&J）
• IPSA（Surgical Innovation）
• Bariatric Balloon Technologies
• Cousin Biotech
• Meritex
• Medigus Ltd.
• Silimed
• Endo-Surf Inc.
• AJM Medical

結論與建議

Global Intragastric Balloons Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 203.34 Million in 2025 to USD 485.4 Million by 2033, growing at a CAGR of 11.42% during the forecast period (2026-2033).

The global intragastric balloon market is experiencing significant growth, driven by expanded insurance reimbursement for obesity treatments, which enhances patient adoption and revenue potential. As insurance payers acknowledge the health benefits of reduced diabetes and cardiovascular risks, gastroenterology centers are investing in necessary training and equipment for balloon placement. This trend is supported by increased collaboration between European hospitals and compliance-tracking platforms, improving patient outcomes. Additionally, the introduction of innovative biodegradable balloons is poised to capture market share as regulatory processes in Asia accelerate. Furthermore, artificial intelligence is transforming patient selection through data analysis of health records and lifestyle data, enabling personalized treatment plans that improve outcomes and streamline clinic operations, thereby reinforcing the market's upward trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intragastric Balloons market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intragastric Balloons Market Segments Analysis

Global intragastric balloons market is segmented by product type, material, procedure, application, end-user and region. Based on product type, the market is segmented into Single Balloons, Dual Balloons and Swallowable Balloons. Based on material, the market is segmented into Silicone, Saline-Filled and Gas-Filled. Based on procedure, the market is segmented into Endoscopic Placement and Swallowable (Non-Endoscopic). Based on application, the market is segmented into Obesity Treatment and Pre-Bariatric Surgery. Based on end-user, the market is segmented into Hospitals, Bariatric Centers and Outpatient Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intragastric Balloons Market

The growing consumer inclination towards non-surgical weight management options is significantly boosting the demand for intragastric balloons. Patients are increasingly seeking effective alternatives that minimize operative risks and shorten recovery times, which leads to wider acceptance of endoscopic procedures and broadens the eligible patient demographics. This shift not only encourages manufacturers to invest more in product development and marketing strategies but also enhances the overall market visibility. Furthermore, the favorable safety perception, coupled with heightened physician confidence and the accessibility of minimally invasive techniques, is driving clinical referrals and laying the groundwork for sustained growth in the intragastric balloon sector.

Restraints in the Global Intragastric Balloons Market

The global intragastric balloons market faces significant restraints due to complex regulatory pathways demanding extensive clinical evidence and compliance documentation, which often prolongs product launch timelines. Manufacturers must invest considerable resources to meet stringent safety standards and navigate varying regional regulations, ultimately delaying market entry and inflating development costs. This scenario often dissuades smaller firms from entering the market, stifling overall innovation and growth prospects within the sector. Additionally, regulatory uncertainty fosters reluctance among investors, as the potential for varying approval outcomes can impact return on investments, leading to more cautious funding approaches that further hinder market expansion.

Market Trends of the Global Intragastric Balloons Market

The Global Intragastric Balloons market is witnessing a remarkable shift towards minimally invasive weight-loss solutions, as both patients and clinicians prioritize procedures that minimize hospital stays, postoperative pain, and recovery times. This trend positions intragastric balloon therapy as a highly sought-after alternative to traditional surgical bariatric options. As healthcare providers enhance outpatient capabilities through advanced endoscopic technologies for efficient balloon insertion and removal, insurers are increasingly acknowledging the cost-effectiveness of these procedures. Consequently, manufacturers are innovating materials for improved durability and ease of use, while forging partnerships with endoscopy device companies to develop integrated solutions that resonate with the global preference for minimally invasive healthcare options.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Intragastric Balloons Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Single Balloons
• Dual Balloons
• Swallowable Balloons

Global Intragastric Balloons Market Size by Material & CAGR (2026-2033)

• Market Overview
• Silicone
• Saline-Filled
• Gas-Filled

Global Intragastric Balloons Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Endoscopic Placement
• Swallowable (Non-Endoscopic)

Global Intragastric Balloons Market Size by Application & CAGR (2026-2033)

• Market Overview
• Obesity Treatment
• Pre-Bariatric Surgery

Global Intragastric Balloons Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Bariatric Centers
• Outpatient Clinics

Global Intragastric Balloons Market Size by Region & CAGR (2026-2033)

• Market Overview
• North America
• Europe
• Middle East

Global Intragastric Balloons Market Size & CAGR (2026-2033)

• North America (Product Type, Material, Procedure, Application, End-User, Region)
  • US
  • Canada
• Europe (Product Type, Material, Procedure, Application, End-User, Region)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material, Procedure, Application, End-User, Region)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material, Procedure, Application, End-User, Region)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material, Procedure, Application, End-User, Region)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Apollo Endosurgery (ORBERA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obalon Therapeutics (ReShape Lifesciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reshape Medical (ReShape Lifesciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spatz Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allurion Technologies (Elipse)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endalis (Endotools)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMI Medical (Helioscopie)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Innovation Developpement (MID)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioenterics Corporation (Allergan/AbbVie)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medsil (Russian)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicone Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon (J&J)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IPSA (Surgical Innovation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bariatric Balloon Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cousin Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meritex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medigus Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Silimed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo-Surf Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJM Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations